Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-17

Clinical Trial Update: Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating hexaminolevulinate photodynamic therapy for female genital erosive lichen planus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hexaminolevulinate PDT (hexaminolevulinate photodynamic therapy)

Snippet

Sponsor: Oslo University Hospital | Conditions: Genital Lichen Planus | Phase 2, Phase 3 | Status: COMPLETED